Oncology and Hematology - Global Oncology Academy

449-464 of 789

Investigating the Impact of Exercise on Cancer Immunotherapy Outcomes
Investigating the Impact of Exercise on Cancer Immunotherapy Outcomes
Project Oncology®
Investigating the Impact of Exercise on Cancer Immunotherapy Outcomes
Samhitha Gundakaram, MBBS
- Samhitha Gundakaram, MBBS
Early-Onset Endometrial Cancer: Bridging the Gap Between Age and Outcome
Early-Onset Endometrial Cancer: Bridging the Gap Between Age and Outcome
Project Oncology®
Early-Onset Endometrial Cancer: Bridging the Gap Between Age and Outcome
Androgen Receptor Emerges as a Marker of Differentiation in Endometrial Cancer
Androgen Receptor Emerges as a Marker of Differentiation in Endometrial Cancer
Project Oncology®
Androgen Receptor Emerges as a Marker of Differentiation in Endometrial Cancer
Investigating At-Home Subcutaneous Atezolizumab for NSCLC: An Ongoing Study
Investigating At-Home Subcutaneous Atezolizumab for NSCLC: An Ongoing Study
Project Oncology®
Investigating At-Home Subcutaneous Atezolizumab for NSCLC: An Ongoing Study
Jorge Nieva, MD
- Jorge Nieva, MD
Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
Project Oncology®
Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
George Laliotis, MD, MPH, MHA
- George Laliotis, MD, MPH, MHA
Stratifying ICI-P Risk in Non-Small Cell Lung Cancer with Genetic and Radiographic Markers
Stratifying ICI-P Risk in Non-Small Cell Lung Cancer with Genetic and Radiographic Markers
Project Oncology®
Stratifying ICI-P Risk in Non-Small Cell Lung Cancer with Genetic and Radiographic Markers
Overall Survival with Neoadjuvant Therapy in HNSCC: Examining Real-World Data
Overall Survival with Neoadjuvant Therapy in HNSCC: Examining Real-World Data
Project Oncology®
Overall Survival with Neoadjuvant Therapy in HNSCC: Examining Real-World Data
Vanessa Helou, MD
- Vanessa Helou, MD
TIL^plus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
TIL^plus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
Project Oncology®
TIL^plus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
Project Oncology®
Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
Personalizing Prostate Cancer Surveillance: Insights from Canary PASS
Personalizing Prostate Cancer Surveillance: Insights from Canary PASS
On the Frontlines of Prostate Cancer
Personalizing Prostate Cancer Surveillance: Insights from Canary PASS
Lisa Newcomb, PhD
- Lisa Newcomb, PhD
Active Surveillance of Prostate Cancer: Evaluating Long-Term Outcomes
Active Surveillance of Prostate Cancer: Evaluating Long-Term Outcomes
On the Frontlines of Prostate Cancer
Active Surveillance of Prostate Cancer: Evaluating Long-Term Outcomes
Lisa Newcomb, PhD
- Lisa Newcomb, PhD
Evolving Strategies in Limited-Stage Small Cell Lung Cancer Management
Evolving Strategies in Limited-Stage Small Cell Lung Cancer Management
Global Oncology Academy
Evolving Strategies in Limited-Stage Small Cell Lung Cancer Management
Gerard A. Silvestri MD, MS; Anurag Singh, MD
- Gerard A. Silvestri MD, MS
- Anurag Singh, MD
- Adam H. Fox, MD, MSc
- Mariam Alexander, MD, PhD
Understanding Extensive-Stage Small Cell Lung Cancer: Advancements and Ongoing Challenges
Understanding Extensive-Stage Small Cell Lung Cancer: Advancements and Ongoing Challenges
Global Oncology Academy
Understanding Extensive-Stage Small Cell Lung Cancer: Advancements and Ongoing Challenges
Gerard A. Silvestri MD, MS; Anurag Singh, MD
- Gerard A. Silvestri MD, MS
- Anurag Singh, MD
- Adam H. Fox, MD, MSc
- Mariam Alexander, MD, PhD
Stratifying Advanced Endometrial Cancer: Real-World Outcomes by Molecular Subtype
Stratifying Advanced Endometrial Cancer: Real-World Outcomes by Molecular Subtype
Project Oncology®
Stratifying Advanced Endometrial Cancer: Real-World Outcomes by Molecular Subtype
Redefining Risk in Endometrial Cancer: Recurrence Prediction with Machine Learning
Redefining Risk in Endometrial Cancer: Recurrence Prediction with Machine Learning
Project Oncology®
Redefining Risk in Endometrial Cancer: Recurrence Prediction with Machine Learning
Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
On the Frontlines of Prostate Cancer
Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
Daniel J. George, MD
- Daniel J. George, MD

29/11